3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
16
Leukemia, Myeloid, Chronic-Phase
6
Neoplasm Metastasis
4
Neoplasms
3
Philadelphia Chromosome
2
Ovarian Neoplasms
2
Myeloproliferative Disorders
2
Leukemia
2
Synovitis, Pigmented Villonodular
1
Sarcoma
1
Recurrence
1
Peritoneal Neoplasms
1
Neoplasm, Residual
1
Melanoma
1
Leukemia, Myeloid
1
Hematologic Diseases
1
Giant Cell Tumor of Tendon Sheath
1
Genital Neoplasms, Female
1
Gastrointestinal Stromal Tumors
1
Fallopian Tube Neoplasms
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Chordoma
1
Cholangiocarcinoma
1
Breast Neoplasms
1
Blast Crisis
1
Appendiceal Neoplasms
1
Anatomic Stage I Breast Cancer AJCC v8
1
Interventions
talimogene laherparepvec
1
mirdametinib
1
Restraint, Physical
1
Mn-PyC3A
1
Elasticity Imaging Techniques
1
Deoxycholic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neurofibroma
×
nilotinib
×
1 year
×
Clear all
No trials found.